{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-077431","form_type":"8-K","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2025-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.016120+00:00","generated_at":"2026-05-17T12:29:11.091220+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"OS Therapies amends bylaws to reduce stockholder meeting quorum to one-third of voting power","bullets":["Board approved amendment to Section 3.10 of Article III of the Bylaws on August 15, 2025.","Quorum for stockholder meetings changed to one-third of the voting power of outstanding shares entitled to vote, present in person or by proxy.","Amendment filed as Exhibit 3.1 via prospectus supplement on Form S-3ASR; no sale of securities by DoD is implied.","No proceeds to company; DoD may convert preferred stock or exercise warrant to receive up to 24,521,672 common shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-077431","json":"https://secwatch.observer/filing/0001213900-25-077431.json","markdown":"https://secwatch.observer/filing/0001213900-25-077431.md","text":"https://secwatch.observer/filing/0001213900-25-077431.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025077431/0001213900-25-077431-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025077431/ea0253338-8k_ostherap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:29:11.091220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c5455a113b91316f1636b6c0c45b588aa2473bbb","claim":"OS Therapies Inc: Amended Section 3.10 of Bylaws to change stockholder meeting quorum to one-third of voting power entitled to vote, present in person or by proxy (effective 2025-08-15).","evidence_excerpt":"On August 15, 2025, the Board of Directors (the “Board”) of OS Therapies Incorporated (the “Company”) approved and adopted an amendment (the “Amendment”) to Section 3.10 of Article III of the Company’s Amended and Restated Bylaws (the “Bylaws”), effective as of such date, to change the quorum for the transaction of business at stockholder meetings to one-third of the voting power of the outstanding shares of stock of the Company entitled to vote on a matter at the meeting, present in person or represented by proxy.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025077431/0001213900-25-077431-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-08-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}